Jonathan Schott
@jmschott
Prof @drcionucl • Neurologist @uclh • @MRC Investigator • @nihr Senior Investigator • CMO @alzresearchuk • Fellow @acmedsci • Dementia, ageing, biomarkers
I’m honoured to be taking up my new role with @AlzResearchUK and look forward to contributing to the team effort needed to makes transformative changes to people living with, or at risk of, dementia @drcionucl
We’re delighted to announce our new Chief Medical Officer, @UCL’s Prof @jmschott, who will play a pivotal role in supporting and shaping ongoing research, policy, advocacy and strategy work to help deliver life-changing dementia research. Let’s #MakeBreakthroughsPossible!
I’m honoured to be joining the DRI as a group leader — and look forward to helping translate the amazing science being done there into benefits for people with, and at risk of, dementia. @ARUKscientist @NIHRresearch @acmedsci @UCLBrainScience
We're excited to welcome a new Group Leader to the UK DRI at UCL! 🙌 🎉 🥳 Prof @jmschott’s clinical practice & research are centred on the dementias with a focus on early accurate diagnosis and detection of pre-symptomatic Alzheimer’s disease👉buff.ly/LxEvpCH
Just out in @ArqNeuroPsiq. Pros and cons of antiamyloid therapies for Alzheimer's disease. Opinion papers by Professors @jmschott, @charl_marshall, Ricardo Nitrini and Adalberto Studart Neto.
🧠💬Donanemab, recently approved worldwide, was authorized by ANVISA on April 17. Experts discuss PROS, CONS, and future use of this anti-amyloid therapy for Alzheimer’s in Brazil. ✅ fcj9.short.gy/xZQycs ❌ fcj9.short.gy/5tWu06 ⚖️ fcj9.short.gy/O92ebO
am honoured to be appointed an @NIHRresearch Senior investigator. I look forward to helping provide research leadership to the NIHR Faculty, and promoting the next generation of researchers working to improve outcomes for patients @uclh @UKDRI @AlzResearchUK @UCLHresearch
❗We are pleased to announce the latest cohort of Senior Investigators. This new cohort signals NIHR’s ongoing commitment to broadening participation in health and care research leadership. This includes notable regional growth in Yorkshire and the Humber and the South West and…
Latest @MRCLHA Insight 46 paper — TL/DR: midlife air pollution influences late life cognitive function. Full text @LancetLongevity authors.elsevier.com/sd/article/S26…
@asjdseesit @dfmcauley @Bernade84181190 @OFMPP David Beverland Henrik Zetterberg @jmschott Amanda Heslegrave Elena Veleva @RhiannonLaban @aoifemsweeney
Pleased to be able to contribute to this huge international effort led by @RikOssenkoppele and colleagues @biofinder_study exploring tau PET in n=12,048 individuals *open access* paper here: nature.com/articles/s4159…
Are you a UK health professional working in dementia? If so, please take this *5 min* survey to help @AlzResearchUK better understand the views of HCPs working across the NHS. Thank you! forms.office.com/Pages/Response…
Congratulations on a great defence, Anika!
Yesterday, Anika brilliantly defended her PhD thesis on the fole of MTL in Alzheimer’s disease. It was a brilliant discussion with @jmschott between peers. Congratulations Dr. Wuestefeld! You did a great job👏👏👏
We’re proud to see our Chief Medical Officer, @jmschott named a Group Leader at the UK DRI at UCL!
We're excited to welcome a new Group Leader to the UK DRI at UCL! 🙌 🎉 🥳 Prof @jmschott’s clinical practice & research are centred on the dementias with a focus on early accurate diagnosis and detection of pre-symptomatic Alzheimer’s disease👉buff.ly/LxEvpCH
Latest open access @MRCLHA Insight 46 paper — remote cognitive testing in a healthy elderly population is feasible #online46 #cognitron alz-journals.onlinelibrary.wiley.com/doi/10.1002/da…
My son Otto is doing the London-Brighton cycle to raise funds for @ARUKscientist @AlzResearchUK next weekend — please support if you can! #JustGiving justgiving.com/page/team-otto…
Great to see this out! Thanks for leading this, Nick and of course to @AlamarBio
Fluid biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay @AlamarBio @andrealessa alz-journals.onlinelibrary.wiley.com/doi/10.1002/al…
Honoured to be elected @acmedsci FMedSci and to be in such distinguished company ucl.ac.uk/news/2025/may/… @ucl @AlzResearchUK @alzassociation @UKDRI
🌞 How can you take care of your brain health in the summer months? Ahead of #DementiaActionWeek, Prof @jmschott (@UCLIoN) shares his top tips. buff.ly/vMs2Agu
James et al. report that brain rejuvenation factors in adults with genetic and sporadic neurodegenerative diseases may offer new insights into slowing brain aging and improving cognitive function. Please read at: buff.ly/s4oQbcB @Sarah_Naomi_1 @jmschott @MRCLHA
Led by @zedzeinab we explored the pathology of PCA, a rare, visual, usually young onset form of Alzheimer's vs typical AD. TD,DR: there are differences in the topography of both AD pathology & microglial responses. Free full text here: onlinelibrary.wiley.com/doi/full/10.11…
“There’s great progress being made in biomarker technology…We need to push ahead” — @jmschott on the state of biomarker tools.
Congratulations to the BRC-supported researchers who have been appointed or re-appointed as @NIHRresearch Senior Investigators in the 2025 round of awards, Prof @jmschott, Prof @soniajohnson, Prof Henry Houlden & Prof @RHeyderman 🔗uclhospitals.brc.nihr.ac.uk/news/brc-resea…
The Alzheimer's Association Global Biomarker Standardization Consortium evaluated p-tau assays to determine which assay has the greatest fold change between AD and non-AD. Explore findings recently published in Alzheimer's & Dementia alz-journals.onlinelibrary.wiley.com/doi/full/10.10… #AlzResearch
10th annual @UCLIoN neurology course is this June. Book your place now. ucl.ac.uk/ion/neurology-…
